Concurrent Infection of Influenza and COVID-19: A Review


Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2025 | Volume : 02 | 01 | Page : –
    By

    Abrar Ahmad Zargar,

  • Arvind Kumar,

  • Ranjeet Kumar,

  1. Assistant professor, Department of Pharmacy at SVS Paramedical college, Jammu, India
  2. Assistant Professor, Department of Pharmacy, RBMI Group of Institutions, Bareilly, Utter Pradesh, India
  3. Associate Professor, Narayan Institute of Pharmacy, Gopal Narayan Singh University, Sasaram, Rohtas, Bihar, India

Abstract

In December 2019, a novel coronavirus that causes respiratory illnesses was identified in Wuhan, China, and swiftly spread around the world. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a virus that spreads via the respiratory system and can cause pneumonia. Members of the Orthomyxoviridae family include influenza viruses. Although there are four genera in this family, influenza is only caused by genera A and B, which are clinically important for humans. Coinfection occurs when a person comes into touch with multiple viruses or infections at the same time. Regarding methods and processes of transmission, clinical features, and related immune reactions, SARS-CoV-2 is similar to influenza in a number of ways. Given the significance of the aforementioned co-infection and the approaching flu season, it is imperative to comprehend the similarities and differences between the immunopathogenesis, symptoms, and therapy of the flu virus and SARS-CoV-2. Both infections may cause pathological events and illnesses, including fever, inflammation, lymphopenia, coagulation, DIC (disseminated intravascular coagulation), gastrointestinal issues, elevated acute phase proteins (APPs), ARDS (acute respiratory distress syndrome), multi-organ failure, and mortality. So, we discussed over the flu-covid-19 coinfection, the similarities and differences, risk factors, virology, immunisations, and the immunological similarities and differences between influenza and COVID-19.

Keywords: Coinfection, covid-19, influenza, SARS-CoV-2, virology, vaccinations.

How to cite this article:
Abrar Ahmad Zargar, Arvind Kumar, Ranjeet Kumar. Concurrent Infection of Influenza and COVID-19: A Review. International Journal of Virus Studies. 2024; 02(01):-.
How to cite this URL:
Abrar Ahmad Zargar, Arvind Kumar, Ranjeet Kumar. Concurrent Infection of Influenza and COVID-19: A Review. International Journal of Virus Studies. 2024; 02(01):-. Available from: https://journals.stmjournals.com/ijvs/article=2024/view=186494


References

  1. Ozaras R, Cirpin R, Duran A, Duman H, Arslan O, Bakcan Y, Kaya M, Mutlu H, Isayeva L, Kebanlı F, Deger BA. Influenza and COVID‐19 coinfection: report of six cases and review of the literature. Journal of Medical Virology. 2020 Nov;92(11):2657-65.
  2. Venkatram S, Alapati A, Dileep A, Diaz‐Fuentes G. Change in patterns of hospitalization for influenza during COVID‐19 surges. Influenza and other Respiratory Viruses. 2022 Jan;16(1):72-8.
  3. https://www.businessinsider.in/science/health/news/covid-19-and-flu-coinfection-rising-in-india-who-warns-it-may-escalate-in-the-winters/articleshow/94682987.cms. Assessed on 23 October, 2022.
  4. https://www.livemint.com/science/health/covid-flu-coinfection-on-rise-how-fatal-is-it-and-what-are-the-symptoms-11664708613992.html. Assessed on 18 October, 2022.
  5. https://medcraveonline.com/mojph/mojph-11-00394.pdf. Assessed on 22 October, 2022.
  6. Alosaimi, B., Naeem, A., Hamed, M. E., Alkadi, H. S., Alanazi, T., Al Rehily, S. S., … & Zafar, A. (2021). Influenza co-infection associated with severity and mortality in COVID-19 patients. Virology Journal, 18(1), 1-9.
  7. İslamoğlu, M. S., & Börkü Uysal, B. (2021). Influenza and SARS-CoV-2 coinfection during the COVID-19 pandemic.
  8. Cheng, Y., Ma, J., Wang, H., Wang, X., Hu, Z., Li, H., … & Liu, X. (2021). Co‐infection of influenza A virus and SARS‐CoV‐2: A retrospective cohort study. Journal of Medical Virology, 93(5), 2947-2954.
  9. Kondo, Y., Miyazaki, S., Yamashita, R., & Ikeda, T. (2020). Coinfection with SARS-CoV-2 and influenza A virus. BMJ Case Reports CP, 13(7), e236812.
  10. Gubernot, D., Jazwa, A., Niu, M., Baumblatt, J., Gee, J., Moro, P., … & Bennett, S. (2021). US Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines. Vaccine, 39(28), 3666-3677.
  11. https://www.who.int/health-topics/coronavirus#tab=tab_2. Assessed on 23 October, 2022.
  12. https://www.sciencedaily.com/releases/2022/03/220325220651.htm. Assessed on 23 October, 2022.
  13. Adams K. Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged 18 Years Who Were Hospitalized or Died with Influenza—United States, 2021–22 Influenza Season. MMWR. Morbidity and Mortality Weekly Report. 2022;71.
  14. Liu, S., Li, W., & Jiang, S. (2022). Disease of influenza virus and SARS-CoV-2 coinfection: Flurona or Flucovid? Journal of Medical Virology.
  15. https://www.washingtonpost.com/health/2022/01/05/flurona-coronavirus-flu-symptoms/. Assessed on 23 October, 2022.
  16. https://www.timesofisrael.com/flurona-israel-records-its-first-case-of-patient-with-covid-and-flu-at-same-time/. Assessed on 18 October, 2022.
  17. https://www.aha.org/flurona-and-its-impact-flu-season. Assessed on 10 October, 2022.
  18. https://www.moneycontrol.com/news/world/florona-not-a-new-variant-but-a-blend-of-covid-and-flu-all-that-matters-explained-7892091.html. Assessed on 18 October, 2022.
  19. Konala VM, Adapa S, Gayam V, Naramala S, Daggubati SR, Kammari CB, Chenna A. Co-infection with Influenza A and COVID-19. European journal of Case Reports in Internal Medicine. 2020;7(5).
  20. https://www.cdc.gov/flu/symptoms/flu-vs-covid19.htm. Assessed on 23 December, 2022.
  21. https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-vs-flu/art-20490339. Assessed on 23 December, 2022.
  22. https://asm.org/Articles/2020/July/COVID-19-and-the-Flu. Assessed on 23 December, 2022.
  23. Flerlage T, Boyd DF, Meliopoulos V, Thomas PG, Schultz-Cherry S. Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract. Nature Reviews Microbiology. 2021 Jul;19(7):425-41.
  24. Kakodkar P, Kaka N, Baig MN. A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19). Cureus. 2020 Apr 6;12(4).
  25. https://norgenbiotek.com/blog/covid-flu-and-you. Assessed on 24 December, 2022.
  26. Khorramdelazad H, Kazemi MH, Najafi A, Keykhaee M, Emameh RZ, Falak R. Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection. Microbial Pathogenesis. 2021 Mar 1; 152:104554.
  27. Zolfaghari Emameh R, Nosrati H, Eftekhari M, Falak R, Khoshmirsafa M. Expansion of single cell transcriptomics data of SARS-CoV infection in human bronchial epithelial cells to COVID-19. Biological Procedures Online. 2020 Dec;22(1):1-0.
  28. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. The lancet. 2020 Mar 28;395(10229):1033-4.
  29. Leon LR. Invited review: cytokine regulation of fever: studies using gene knockout mice. Journal of Applied Physiology. 2002 Jun 1;92(6):2648-55.
  30. Conti B, Tabarean I, Andrei C, Bartfai T. Cytokines and fever. Frontiers in Bioscience-Landmark. 2004 May 1;9(2):1433-49.
  31. Brandes M, Klauschen F, Kuchen S, Germain RN. A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell. 2013 Jul 3;154(1):197-212.
  32. Iwasaki A, Pillai PS. Innate immunity to influenza virus infection. Nature Reviews Immunology. 2014 May;14(5):315-28.
  33. Yang Y, Tang H. Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia. Cellular & Molecular Immunology. 2016 Jul;13(4):432-42.
  34. Schultze, J. L., & Aschenbrenner, A. C. (2021). COVID-19 and the human innate immune system. Cell, 184(7), 1671-1692.
  35. Richards S, Shokrani M. Comparing the structure, diagnosis, and prevention of SARS-CoV-2 and influenza. MLO: Medical Laboratory Observer. 2021:8-18.
  36. Pawlowski C, Silvert E, O’Horo JC, Lenehan PJ, Challener D, Gnass E, Murugadoss K, Ross J, Speicher L, Geyer H, Venkatakrishnan AJ. SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes. PNAS nexus. 2022 Jul;1(3): pgac071.
  37. Dadashi M, Khaleghnejad S, Abedi Elkhichi P, Goudarzi M, Goudarzi H, Taghavi A, Vaezjalali M, Hajikhani B. COVID-19 and influenza co-infection: a systematic review and meta-analysis. Frontiers in medicine. 2021 Jun 25; 8:681469.
  38. Yan X, Li K, Lei Z, Luo J, Wang Q, Wei S. Prevalence and associated outcomes of co-infection between SARS-CoV-2 and influenza: a systematic review and meta-analysis. International Journal of Infectious Diseases. 2023 Aug 28.
  39. Rezaee, D., Bakhtiari, S., Jalilian, F. A., Doosti-Irani, A., Asadi, F. T., & Ansari, N. (2023). Coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus during the COVID-19 pandemic. Archives of Virology, 168(2), 53.
Ahead of Print Subscription Review Article
Volume 02
01
Received 18/11/2024
Accepted 26/11/2024
Published 30/11/2024
Publication Time 12 Days
Total Visits: 252


Loading citations…

PlumX Metrics